Subscribe to Newsletter

Content by Stephanie Vine:

Discovery & Development Ingredients

From Plastic Pollution to Pharma Compounds

| Stephanie Vine | 3 min read

How fungi help turn ocean trash into pharmaceutical platform molecules.

Business & Regulation Business Practice

Social Media Reacts to Eli Lilly’s Price Reduction of Insulin

| Stephanie Vine | 4 min read

What does social media have to say about Eli Lilly’s insulin price reduction?

Business & Regulation Profession

No One Left Behind

| Stephanie Vine | 10 min read

We speak with Eric Dube, CEO of Travere Therapeutics, about his career and thoughts on leadership.

Manufacture Advanced Medicine

A Patient Story In The UK

| Stephanie Vine | 2 min read

Libmeldy gene therapy is used for the first time in the UK outside of a clinical trial.

Manufacture Bioprocessing - Upstream & Downstream

Video: Natalia Elizalde Discusses the Challenges of Viral Vectors

| Stephanie Vine

A video interview discussing the challenges of viral vectors

Manufacture Advanced Medicine

Video: Ivan Wall Speaks Out About Cell and Gene Training

| Stephanie Vine

A video interview addressing the need for training in cell and gene therapy manufacturing.

Manufacture Advanced Medicine

Video: Stuart Gibb On The Importance of Collaboration

| Stephanie Vine

A video interview covering collaboration in cell and gene therapy manufacturing

Business & Regulation Marketing

Video: Kim Barnes on Post-Pandemic Pharma Events

| Stephanie Vine

A video interview tackling the post-pandemic challenges of the events industry

Manufacture Advanced Medicine

Video: Vered Caplan Talks Advanced Therapies

| Stephanie Vine

Check out our video interview covering decentralized manufacturing and more.

Business & Regulation Business Practice

Here Come the Humira Biosimilars

| Stephanie Vine | 2 min read

The first Humira biosimilar in the US is here, but market penetration could be a challenge.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register